The global shortage of this rare gas is causing prices to spike. Here’s why junior helium producers could soar this summer.
Big Tech may be in for a major crisis in the coming months, all because of a global shortage virtually nobody’s talking about.
And it has nothing to do with...
Welcome to this special Tactical Tuesday edition of Global Investment Daily! If you thought last week was a whirlwind, grab onto something because things are really heating up. The recent market swoon is sending shockwaves beyond mere 'volatility'. It's a wake-up call for those who thought the bull run...
Big Tech’s AI Gamble: Is Wall Street Ready to Wait?
Welcome to this week’s edition of The Market Pulse, where we dive deep into the critical crossroads of AI innovation, tech earnings, and Wall Street's ticking clock. This week, the Magnificent 7—led by Microsoft, Tesla, Meta, and Apple—report quarterly results,...
This metal is perhaps the most important on the planet right now…And everyone is rushing to secure supply.
But one North American miner may be positioned ahead of the pack, and poised for oversized returns as a result.
Worldwide demand for copper is steadily on the rise, spurred by trillions of dollars being invested in new infrastructure spending projects, and Argentina is vying to become a major player in this sector.
Traditionally, global copper mining has been dominated by Chile, Peru, China, the United States and Australia.
According to...
Markets in a Fog: Tariff Uncertainty and the Road Ahead
In a market that loves clarity, today’s investing landscape feels more like navigating through a dense, uncharted fog. Tariff uncertainty is the name of the game, and even a four-day stock rally isn't quite enough to clear the haze. While...
For people suffering from myasthenia gravis (mg) and other debilitating autoimmune disorders, daily life can be miserable. Patients suffering from mg complain about extreme muscle weakness and fatigue, which can make routine activities like chewing and swallowing very difficult to accomplish.
Immunovant (NASDAQ: IMVT) just reported after early-stage data from...
As the curtain closes on the stock market’s acclaimed ‘good’ season, we stand at the crossroads of profit and prudence. With portfolios plumped up like Thanksgiving turkeys, thanks to a 22% feast since November, the temptation to pocket those gains and saunter into summer is palpable.
But before you decide...
As we head into the fourth week of a significant pullback in the major market averages, the investment landscape is more turbulent than ever. What started as fears of prolonged inflation and relentless interest rate hikes has now morphed into concerns about an impending recession. The narrative has shifted,...
A Market on the Brink… or the Verge of a Turnaround?
After a rough stretch for stocks, investors have been on edge, wondering if there’s any relief in sight. Tariff tensions, rising bond yields, and global uncertainty have weighed on markets, leading to a brutal sell-off. But could there be...




























